Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Other financing activities (2020 - 2025)

Historic Other financing activities for Aveanna Healthcare Holdings (AVAH) over the last 5 years, with Q3 2025 value amounting to $2.5 million.

  • Aveanna Healthcare Holdings' Other financing activities rose 1183333.33% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 18627.34%. This contributed to the annual value of $2.2 million for FY2024, which is 10936.01% up from last year.
  • Latest data reveals that Aveanna Healthcare Holdings reported Other financing activities of $2.5 million as of Q3 2025, which was up 1183333.33% from $1.9 million recorded in Q4 2024.
  • In the past 5 years, Aveanna Healthcare Holdings' Other financing activities ranged from a high of $13.4 million in Q1 2022 and a low of -$5.2 million during Q4 2022
  • For the 4-year period, Aveanna Healthcare Holdings' Other financing activities averaged around $2.6 million, with its median value being $1.9 million (2024).
  • As far as peak fluctuations go, Aveanna Healthcare Holdings' Other financing activities skyrocketed by 1407.84% in 2021, and later soared by 1183333.33% in 2025.
  • Quarter analysis of 4 years shows Aveanna Healthcare Holdings' Other financing activities stood at $4.6 million in 2021, then tumbled by 212.38% to -$5.2 million in 2022, then skyrocketed by 136.92% to $1.9 million in 2024, then skyrocketed by 31.62% to $2.5 million in 2025.
  • Its Other financing activities stands at $2.5 million for Q3 2025, versus $1.9 million for Q4 2024 and $21000.0 for Q3 2024.